Form 4: Gilead Sciences Executive Johanna Mercier Reports Stock Transactions
SEC Form 4 Filing
Johanna Mercier, Chief Commercial Officer of Gilead Sciences, reports the vesting and subsequent sale of restricted stock units.
Summary
- On June 10, 2024, Johanna Mercier, Chief Commercial Officer of Gilead Sciences, reported transactions involving Gilead Sciences common stock.
- Mercier vested 3,751 restricted stock units, each representing the right to receive one share of Gilead Sciences common stock.
- Simultaneously, Mercier disposed of 1,714 shares of common stock at a price of $65.25 per share to cover tax obligations.
- Following these transactions, Mercier directly owns 120,469 shares of Gilead Sciences common stock and 43,697 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives. This filing indicates the normal course of compensation and tax obligation fulfillment for a high-level executive at Gilead Sciences.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of stock transactions (vesting of restricted stock units and sale of shares). |
| 06/11/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.